$6.34
0.294.79%
At Close: -
$6.34
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Zevra Therapeutics
ZVRANASDAQ
Zevra Therapeutics (NASDAQ:ZVRA) Stock, Earnings Estimates, EPS, And Revenue
Zevra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.440
Quarterly Revenue Estimate
$4.4M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$27.7M
Analyze the earnings history of Zevra Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics | -$0.15 | -$0.44 | — | — | $8.47M | $4.41M | — | — | 08/12/2024 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.34 | -$0.48 | -$0.40 | 16.67% | $2.88M | $3.76M | $3.42M | -8.91% | 05/08/2024 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.26 | -$0.27 | -$0.40 | -48.15% | $2.30M | $11.74M | $13.22M | 12.58% | 03/28/2024 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.19 | -$0.30 | -$0.40 | -33.33% | $2.87M | $3.38M | $2.90M | -14.35% | 11/07/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.19 | -$0.39 | -$0.15 | 61.54% | $1.30M | $2.90M | $8.47M | 192.07% | 08/14/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.05 | -$0.23 | -$0.34 | -47.83% | $3.96M | $2.65M | $2.88M | 8.64% | 05/15/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.08 | -$0.17 | -$0.26 | -52.94% | $2.60M | $3.20M | $2.30M | -28.12% | 03/07/2023 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.06 | -$0.13 | -$0.19 | -46.15% | $1.97M | $3.20M | $2.87M | -10.19% | 11/09/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.40 | -$0.12 | -$0.19 | -58.33% | $11.99M | $1.80M | $1.30M | -27.78% | 08/11/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | -$1.61 | -$0.05 | -$0.05 | 0.00% | $12.10M | $3.06M | $3.96M | 29.58% | 05/12/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | — | -$0.07 | -$0.08 | -14.29% | — | $2.23M | $2.60M | 16.59% | 03/30/2022 | Get Alert |
| ZVRA | Zevra Therapeutics | — | -$0.07 | -$0.06 | 14.29% | — | $2.18M | $1.97M | -9.86% | 11/10/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | $0.01 | $0.22 | -$0.40 | -281.82% | $6.91M | $12.10M | $11.99M | -0.94% | 08/12/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.12 | -$0.17 | -$1.61 | -847.06% | $2.09M | $2.10M | $12.10M | 476.19% | 05/13/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.18 | -$0.64 | -$1.07 | -67.19% | $1.38M | $2.00M | $2.37M | 18.30% | 03/11/2021 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.33 | — | $0.01 | — | $0.00 | $6.75M | $6.91M | 2.34% | 08/12/2020 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.46 | — | -$0.12 | — | $0.00 | $5.80M | $2.09M | -63.98% | 05/12/2020 | Get Alert |
| ZVRA | Zevra Therapeutics | — | — | -$0.18 | — | — | — | $1.38M | — | 02/28/2020 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.94 | -$0.19 | $0.06 | 131.58% | $0.00 | $2.93M | $11.46M | 291.23% | 11/14/2019 | Get Alert |
| ZVRA | Zevra Therapeutics | -$0.91 | — | -$0.33 | — | $0.00 | — | $0.00 | — | 08/13/2019 | Get Alert |
Zevra Therapeutics (ZVRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $-0.40 | $-0.48 | 16.7 % |
| Dec 2023 | 2024-03-28 | $-0.40 | $-0.27 | -48.1 % |
| Sep 2023 | 2023-11-07 | $-0.40 | $-0.30 | -33.3 % |
| Jun 2023 | 2023-08-14 | $-0.15 | $-0.39 | 61.5 % |
Zevra Therapeutics (ZVRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $3.43M | $3.76M | -8.91 % |
| Dec 2023 | 2024-03-28 | $13.22M | $11.74M | 12.6 % |
| Sep 2023 | 2023-11-07 | $2.90M | $3.38M | -14.3 % |
| Jun 2023 | 2023-08-14 | $8.47M | $2.90M | 192.1 % |
FAQ
When is Zevra Therapeutics (NASDAQ:ZVRA) reporting earnings?
Zevra Therapeutics (ZVRA) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for Zevra Therapeutics (NASDAQ:ZVRA)?
The Actual EPS was $-0.40, which beat the estimate of $-0.48.
What were Zevra Therapeutics’s (NASDAQ:ZVRA) revenues?
The Actual Revenue was $3.4M, which missed the estimate of $3.8M.
Browse earnings estimates, EPS, and revenue on all stocks.